Imagio® Breast Imaging System
Diagnostic work-up of breast lesions (e.g., BI-RADS 3, 4)
ApprovedActive
Key Facts
Indication
Diagnostic work-up of breast lesions (e.g., BI-RADS 3, 4)
Phase
Approved
Status
Active
Company
About Seno Medical Instruments
Seno Medical Instruments, founded in 2005 and headquartered in San Antonio, Texas, is a commercial-stage diagnostics company. Its flagship product, the Imagio® Breast Imaging System, integrates opto-acoustic and ultrasound technology to help radiologists differentiate between benign and malignant breast lesions in a single, non-invasive exam. Enhanced by its native AI clinical decision support tool, SenoGram®, the system aims to address the inefficiencies, high costs, and patient anxiety associated with the current standard of care for breast cancer diagnosis. The company is focused on commercializing this technology to improve clinical outcomes and practice efficiency.
View full company profile